{"id":76542,"date":"2022-03-31T00:00:00","date_gmt":"2022-03-31T00:00:00","guid":{"rendered":"https:\/\/medgoo.com\/index.php\/2022\/03\/31\/mini-slings-noninferior-to-mid-urethral-slings-for-stress-ui-in-women\/"},"modified":"2022-04-04T17:12:19","modified_gmt":"2022-04-04T17:12:19","slug":"mini-slings-noninferior-to-mid-urethral-slings-for-stress-ui-in-women","status":"publish","type":"post","link":"https:\/\/medgoo.com\/index.php\/2022\/03\/31\/mini-slings-noninferior-to-mid-urethral-slings-for-stress-ui-in-women\/","title":{"rendered":"Mini-Slings Noninferior to Mid-Urethral Slings for Stress UI in Women"},"content":{"rendered":"<h3>\n<p>Rate of patient-reported success similar for women in mini-sling, mid-urethral sling groups at 15 months, 36 months<\/p>\n<\/h3>\n<p><b><\/b><\/p>\n<p><b><\/b><\/p>\n<p>THURSDAY, March 31, 2022 (HealthDay News) &#8212; Single-incision mini-slings are noninferior to mid-urethral slings for women with stress urinary incontinence, according to a study published in the March 31 issue of the <em>New England Journal of Medicine<\/em>.<\/p>\n<p>Mohamed Abdel-Fattah, M.D., from the University of Aberdeen in the United Kingdom, and colleagues compared mini-slings to mid-urethral slings among women at 21 U.K. hospitals during 36 months of follow-up in a pragmatic, noninferiority, randomized trial. A total of 298 women were randomly assigned to receive mini-slings and 298 were randomly assigned to mid-urethral slings.<\/p>\n<p>The researchers found that success was reported by 79.1 and 75.6 percent of patients in the mini-sling and mid-urethral sling groups, respectively, at 15 months (adjusted risk difference, 4.6 percentage points; 95 percent confidence interval [CI], \u00e2\u0088\u00922.7 to 11.8; P < 0.001 for noninferiority). Success was reported by 72 and 66.8 percent of patients, respectively, at the 36-month follow-up (adjusted risk difference, 5.7 percentage points; 95 percent CI, \u00e2\u0088\u00921.3 to 12.8). The percentage of patients with groin or thigh pain at 36 months was 14.1 and 14.9 percent for those with mini-slings and mid-urethral slings, respectively; the percentage with tape or mesh exposure was 3.3 and 1.9 percent, respectively, during the 36-month follow-up. The groups had similar outcomes with respect to quality of life and sexual function, apart from dyspareunia, which was reported by 11.7 and 4.8 percent in the mini-sling and mid-urethral sling groups, respectively.<\/p>\n<p>&#8220;Adjustable anchored mini-slings were noninferior to tension-free mid-urethral slings with respect to patient-reported success at 15 months, and the between-group difference remained similar at 36 months,&#8221; the authors write.<\/p>\n<p><a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2111815\" target=\"_blank\" rel=\"noopener\">Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n<p><a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMe2201166\" target=\"_blank\" rel=\"noopener\">Editorial (subscription or payment may be required)<\/a><\/p>\n<p><i><\/i><\/p>\n<p><i>Copyright \u00a9 2022 <a href=\"https:\/\/www.healthday.com\/\" target=\"_new\" rel=\"noopener\">HealthDay<\/a>. All rights reserved.<\/i><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Rate of patient-reported success similar for women in mini-sling, mid-urethral sling groups at 15 months, 36 months<\/p>\n","protected":false},"author":6,"featured_media":76874,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[11],"class_list":["post-76542","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"_links":{"self":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/76542","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/comments?post=76542"}],"version-history":[{"count":1,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/76542\/revisions"}],"predecessor-version":[{"id":76777,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/76542\/revisions\/76777"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/media\/76874"}],"wp:attachment":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/media?parent=76542"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/categories?post=76542"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/tags?post=76542"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}